In this presentation we will discuss
First trimester US especially TVS is an integral part for confirmation of intrauterine pregnancy and to rule out ectopic pregnancy.
First trimester US helps us in suggesting conceptus viability.
First trimester US especially TVS is very efficient in approaching and evaluating the cause of vaginal bleeding.
In this presentation we will discuss
First trimester US especially TVS is an integral part for confirmation of intrauterine pregnancy and to rule out ectopic pregnancy.
First trimester US helps us in suggesting conceptus viability.
First trimester US especially TVS is very efficient in approaching and evaluating the cause of vaginal bleeding.
Obstetric ultrasound uses sound waves to produce pictures of a baby (embryo or fetus) within a pregnant woman, as well as the mother's uterus and ovaries. It does not use ionizing radiation, has no known harmful effects, and is the preferred method for monitoring pregnant women and their unborn babies.
Obstetric ultrasound uses sound waves to produce pictures of a baby (embryo or fetus) within a pregnant woman, as well as the mother's uterus and ovaries. It does not use ionizing radiation, has no known harmful effects, and is the preferred method for monitoring pregnant women and their unborn babies.
Role of trrans vaginal sonography in early pregnancy as to detect abnormal gestations,early detection of aneuploidies.Study markers for trisomies 13,18,21
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
1. CHAIRMAN : DR. P.H PATIL
CO-CHAIRMAN : DR.V.V HATTIHOLI
PRESENTER : DR. JASREEN SIDANA
2. The FirstTrimester is defined as the first 12
weeks of pregnancy following the last normal
menstrual period.
(some authors refer to early pregnancy as 0 - 10
weeks).
It can be divided into a number of phases, each of
which has typical clinical issues.These phases
are:
1.Conceptus phase : 3 - 5 weeks
2.Embryonic phase : 6 - 9 weeks
3.Fetal phase : 10 - 12 weeks
3. It is a part of WHO recommended 3 antenatal
visits.
To define the cause of vaginal bleeding.
To evaluate pelvic pain.
Palpable mass per abdomen.
To exclude a non viable pregnancy or an
ectopic pregnancy.
To document foetal number in case of
multiple gestation.
4. According to American College of Radiology(ACR) and American
Institute of Ultrasound in medicine (AIUM), Ultrasound during
this period is predominantly concerned with the following
clinical issues:
1.CONFIRMING INTRAUTERINE PREGNANCY (IUP)
2. DATING OFTHE PREGNANCY
3. EARLY PREGNANCY FAILURE
4. NUCHAL LUCENCY
5. ECTOPIC PREGNANCY
6. FIRSTTRIMESTER MASSES
5. Sonographic appearance of the normal IUP
includes the visualization of –
1.GESTATIONAL SAC
2.YOLK SAC
3.EMBRYO AND AMNION
4.EMBRYONIC CARDIAC ACTIVITY
5.UMBILICAL CORD AND CORD CYST
6. 1.GESTATIONAL SAC
Earliest sonographic finding in pregnancy.
The GS is an echogenic ring (formed by chorio-emryonic
cells) surrounding an anechoic centre (as fluid filled).
An ectopic pregnancy will appear the same but it will not
be within the endometrial cavity.
The GS is not identifiable until approximately 4 1/2
weeks with a transvaginal scan and 5 weeks withTAS.
7.
8. Decidual Reaction
The hypertrophic changes of the endometrium which occur
as a hormonal response regardless of the site of
implantation, intrauterine or ectopic.
Before ovulation, endometrial proliferation occurs in
response to the estrogen secretion.
After ovulation, the endometrium becomes thickened, soft
and edematous under the influence of the progesterone.The
glandular epithelium secretes a glycogen rich fluid. If
pregnancy occurs, continued production of progesterone
results in more hypertrophic changes in the endometrial
cells and glands to provide nourishment to the blastocyst.
9. Endometrium in the pregnant
state is actually called
decidua, which has three layers
namely :
1.Decidua capsularis
2.Decidua vera
3.Decidua basalis
10. INTRADECIDUAL SAC SIGN:
First reliable gray scale evidence of an IUP is
visualization of the gestational sac within the
thickened decidua ( echogenic focal area at the site of
implantation).
An intradecidual gestational sac should be
eccentrically located within the endometrium and
should abut the endometrial canal.
It is important to ensure that the sac abuts the
endometrial canal to distinguish an intra-uterine
gestational sac from a decidual cyst.
11.
12. DOUBLE DECIDUAL SIGN
Described by Nyberg et al, as a method to differentiate between an
early IUP and the pseudosac of the ectopic pregnancy.
Visualized by about 5.5 – 6 weeks of GA
It is based on visualization of two echogenic rings.
The inner ring is formed by the gestational sac as an
echogenic ring formed by the decidua capsularis and
chorionic laeve eccetrically.
The outer ring is formed by the echogenic ring of the lining
of the uterus ( formed by decidua parietalis).
13.
14.
15.
16. Normal gestational sac can be differentiated
from pseudosac as the normal GS :
Implants immediately beneath the echogenic
endometrium stripe
As it enlarges, becomes oval in shape
Can be distorted duringTVS examination
GS is filled with chorionic sac fluid that is
normally more echogenic than the amniotic
fluid.
17. 2.YOLK SAC
Transfer of the nutrients to the developing embryo
in the third and fourth week.
Angiogenesis : occurs in the wall of the yolk sac in
the fifth week.Vascular network formed by the
angioblasts in the wall of the yolk sac eventually joins
the fetal circulation via the paired vitelline arteries
and veins through a stalk called vitelline duct.
Hematopoeisis: in fifth week
Determination of the amnionicity of a multifetal
pregnancy.
18. First structure to be
seen normally
within the
gestational sac.
Diagnostic of IUP
TAS: MSD of
10 – 15 mm
TVS :MSD of
8.0 mm.
19. 3. AMNION
Double bleb sign: it is a
sonographic feature where
there is visualisation of a
gestational sac containing
a yolk sac and amniotic
sac giving an appearence of
two small bubbles .The
embryonic disc is located
between the two bubbles.
It can be identified as early as
51/2 weeks when the CRL is
2.0mm.
20.
21. The 2 sacs are clearly visible.
The outer chorion with the
developing placenta and the
inner amnion which will "inflate"
with the production of fetal
urine, to adhere to the chorion
obliterating the residual yolk
sac.
22. EMBRYO
At 51/2 weeks, when the CR length is 2.o mm,
embryonic disc is situated between the yolk
sac and amnion.
As the resolution of the ultrasound
equipment improves, visualization of the
embryonic structures become possible.
23. 4. EMBRYONIC CARDIAC ACTIVITY
Using a trans-vaginal approach the fetal heart beat can be
seen flickering before the fetal pole is even identified.
It will be seen alongside the yolk sac.
It may be below 100 beats per minute but this will increase to
between 120- 180 beats per minute by 7 weeks.
In the early scans at 5-6 weeks just visualizing a heart
beating is the important thing.
Failure to identify fetal cardiac activity in a fetus whose
overall length is greater than 4 mm (approx 4.5 weeks)is an
ominous sign .
24. The very early embryonic
heart will be a subtle flicker.
This may be measured using
M-Mode(avoid Doppler in the
first trimester due to risks of
bioeffects).
Initially the heart rate may be
slow.
It is advisable to compare the
maternal heart rate to
confirm that one is not seeing
an arteriole.
25. 5.UMBILICAL CORD AND CORD CYST
Formed at the end of the sixth week.
Contents : all of which are embedded in
Wharton’s jelly.
Two umbilical arteries
single umbilical vein
allantois
Yolk stalk
26.
27. Cysts and pseudocysts within the cord occur
in first trimester.
Seen usually in 8th week and disappear by 12th
week.
Singular, with a mean size of 5.2 mm.
Originate from the remnants of allantois or
yolk stalk and have an epithelial lining.
If seen in 2nd and 3rd trimester they are
associated with chromosomal abnormalities.
28. In order of their appearance, the following
structures can be measured as indicators of
the gestational age:
1.Gestational sac ( MSD)
2.CRL ( crown – rump length)
3.Biparietal diameter
29. 1.Gestational sac
From 5 – 6 weeks gestation, two methods are
used to assign gestational age by USG:
1. Mean sac diameter
2. Sonographic identification of the
gestational sac contents
30. MEAN SAC DIAMETER : the average internal
diameter of the gestational sac, is calculated
as the mean of theAP, transverse and the
longitudinal diameter.
Normally, a yolk sac will be present when MSD :
8 .0 mm.
Embryo will be present when MSD : 16.0 mm.
31.
32. MSD between 2-14 mm are accurate in
predicting the gestational age, before the
embryo is seen.
33. 2.CROWN – RUMP LENGTH
( up to 11 weeks)
GA closely correlates with CR length from 6
weeks until the end of the first trimester.
The CRL is the length of the embryo or fetus
from the top of its head to the bottom of its
torso.
It is measured as the longest dimension of
the embryo, excluding the yolk sac and
extremities.
34. Once, the embryo can be visualized ( after 7
weeks), the measurement of choice for
estimation of GA becomes crown rump
length.
MSD becomes progressively less reliable for
predictingGA as the first trimester of
pregnancy advances.
35.
36. 3.BIPARIETAL DIAMETER:
By the end of the first trimester, measurement
of the BPD becomes more accurate than the
CRL, which by that time reflects errors due to
biological variabilities.
In addition to BPD, corrected BPD, and HC are
the parameters which involve the fetal head.
37.
38. Rules for measurement of the BPD:
1. Correct plane of section is taken through
the third ventricle and paired thalami.
2. the calvaria should be smooth and
symmetrical bilaterally.
3.the cursors are positioned correctly.
39. Measured from the outer edge of the cranium
nearest the transducer to the inner edge
farthest from the transducer.
Corrected BPD =
square root of BPD X OFD/ 1.265
Significance: it represents the BPD of the
standard shaped head ( one with an OFD /
BPD ratio of 1.265) of the same cross
sectional area.
40. Nuchal translucency is referred to as normal
subcutaneous fluid filled space between the
back of the fetal neck and the overlying skin.
It is a measurement performed during a
specific period in the first trimester (11.3-13.6
weeks).
An increased nuchal translucency is thought to
relate to dilated lymphatic channels.
41. 1. Only values obtained when CRL
values are between 45-84 mm are
considered valid.
2. The lucent region is generally not
septated.
3. The thickness rather than the
appearance (morphology) is
considered to be directly related to
the incidence of chromosomal and
other anomalies.
4. A normal value is usually less than
roughly 2.5-3.0 mm in thickness
however it is maternal age dependent
needs to be matched to exact
gestational age and crown rump
length (CRL).
42. The fetus should be transverse (sagittal) in the imaging plane.
The vertebral column should be facing the bottom of the screen.
Fetal head should not be extended or flexed
Fetus should be floating free of the uterine wall (i.e. amniotic fluid should be
seen between its back and the uterus)
Only the lucency is measured (again differing from nuchal thickness)
Ideally only the head and upper thorax should be included in the
measurement
The level of magnification should be appropriate (fetus should occupy most
of the image).
The widest part of the measurement should be taken
43. The nuchal translucency cannot be
adequately assessed if there is :
Unfavourable fetal lie
Unfavourable GA: CRL < 45 or > 84 mm.
44.
45.
46. Interpretation
Detection rates for aneupliodic
anomalies with nuchal
translucency alone approaches 80 -
90 % with a false positive rate of ~
5%.
Correlation With Serum
Markers
To increase the clinical accuracy of nuchal
lucency, it can be correlated with
serum markers such as
maternal B-HCG
alpha feto protein (AFP)
pregnancy associated plasma
protein A (PAPP-A)
oestriol
Further work up
If abnormal > further work up is carried out
which includes
Amniocentesis and / or ChorionicVillus
sampling
Fetal echocardiography
Natural course - progression
As the second trimester approaches, the
region of nuchal translucency might either
Regress :
if chromosomally normal, a large
proportion of fetuses will have a normal
outcome
spontaneous regression does not
however mean a normal karyotype
Evolve into a
Nuchal Oedema
Cystic Hygroma
47. Can be done using sonographic criteria:
1. Embryonic cardiac activity
2. Gestational sac features
3. Amnion and yolk sac criteria
4. Doppler ultrasound assessment
48. 1. Embryonic cardiac activity
The presence of cardiac activity indicates that
the embryo is alive.
The absence of cardiac activity does not
necessarily indicate embryonic demise,
however, because TVS can identify a normal
early embryo without cardiac activity.
49. Embryonic bradycardia:
Doubilet and Benson found that a heart rate
less than 80 beats / min in embryos with a
CRL less than 5.0 mm was universally
associated with subsequent embryonic
demise.
Normal : (120 or more beats/ min)
Arrhythmias :
another indicator of the first trimester loss.
Most common is ventricular bradycardia.
50.
51. 2.Gestational sac features
Abnormal size :
Nyberg et al refined the definition of an
abnormal gestational sac as MSD of 25.0mm
or more without an embryo, or MSD of 20.0
mm or more without a yolk sac.
52. Bromley et al found that
difference between the
MSD and CRL should not
be less than 5.0 mm.
So if, between to 9 weeks’
GA with MSD less than
5.0mm greater than CRL.
( i.e MSD- CRL =
<5.0mm), sometimes
termed as early
oligohydramnios.
53. Other features include :
• Distorted GS shape
• Thin trophoblastic reaction
• Weakly echogenic trophoblast
• Abnormally low position of the GS within the
endometrial cavity.
54.
55. 4. Amnion and yolk sac criterion
Visualization of the amnion in the absence of a
sonographically demonstrable embryo after 7
weeks’ MA is abnormal and diagnostic of the non
viable pregnancy.
The amnion is visualized after the embryo. So it
should never be visualized in the absence of the
embryo.
Other findings that may be useful in the
diagnosis of the embryonic demise include a
collapsing, irregularly marginated amnion and yolk
sac calcification.
56.
57.
58. Yolk sac size :
Internal diameter
of the yolk sac
greater than 5.6
mm between 5
and 10 weeks is
always
associated with
the abnormal
outcome.
59.
60. In general if the MSD is 16 mm or greater and no fetal pole / yolk sac
can be identified on trans-vaginal scanning then this suggests a non-
viable pregnancy (an-embryonic pregnancy).
Repeat scanning with an larger MSD and serial quantitative beta-
HCGs is however thought prudent.
In a normal early pregnancy, the diameter of the yolk sac should
usually be < 6 mm while its shape should be near spherical.
Natural course
As the pregnancy advances, the yolk sac disappears and is
often sonographically not detectable after 14 weeks.
61. Other abnormalities include :
Calcified yolk sac : shadowing echogenic mass.
Seen with a dead embryo and may calcify
within 36 hours after demise.
62. Doppler ultrasound assessment:
Assessment of the uterine or spiral arteries for:
1.Resistive index
2.Pulsatility index
In the normal pregnancy, the indices within
these vessels demonstrate a progressive
decline from 6 to 12 weeks of POG.
the basis for this drop in early pregnancy is
the development of the intervillous
circulation.
63. 1.Resistive index
If RI < 0.55 - normal pregnancy
If RI >0.55 - corresponds to the high pressure
blood flow, seen in cases with pre eclampsia
and IUGR. Subsequently, leading to
miscarriage resulting in early pregnancy
failure.
64. 2. Pulsatility index
Higher in the women with recurrent
pregnancy loss and
Elevated levels of antiphospholipid
antibodies.
65.
66. A CRL of ≥ 7mm without a heart beat
on a transvaginal ultrasound confirms
the diagnosis
Additional clues are presence of
abnormal hyperechoic material within
the uterine cavity and an irregular
gestational sac.
If there is an absence of heart beat in a
fetus that is less than 7mm, the
diagnosis of miscarriage cannot be
made with certainty.
This scenario is termed "Pregnancy Of
UncertainViability (PUV)", and
followup with ultrasound (generally in
7-10 days) and serial bHCG
recommended.
68. A subchorionic haemorrhage is often seen,
but unless large does not carry a poor
prognosis.
Features which do predict poor outcome
include:
• Fetal bradycardia : < 80 - 90 bpm
• Small or Irregular Gestational Sac : MSD -
CRL < 5 mm
• Large Subchorionic Haemorrhage
69.
70. One important difference is to be deduced
between an actual irregular sac & a sac which
appears irregular due to Braxton-Hick’s
contractions.
The former one, will not change its shape
to become normal with time.
71. Refers to the presence of
an open cervix in the
context of bleeding in the
first trimester of
pregnancy.
Essentially, a threatened
abortion progresses to an
inevitable abortion if
cervical dilatation
occurs. Once tissue has
passed through the
cervical os, this will then be
termed an incomplete
abortion and ultimately
a complete abortion.
72. Shows an empty
uterus with no
fetal components
or products of
conception
73. Retained Products of Conception, still seen within
the uterine / cervical cavity.
74. An anembryonic
pregnancy may be
diagnosed when there
is no fetal
pole identified on trans-
vaginal scanning the size
of the gestational sac is
such that a fetal pole
should be seen.
MSD ≥ 25 mm (by RCOG
criteria)
There is little or no growth
of the gestational sac
between interval scans
Normally the MSD should
increase by 1 mm per day
If MSD is too small to
ascertain viability on the
initial ultrasound, a follow
up scan in 10-14 days
should differentiate early
pregnancy from a failed
pregnancy
75.
76. Other ancillary features
include
Absent yolk sac
when MSD > 8 mm
Poor decidual reaction :
often < 2 mm
Irregular gestational
sac shape
Abnormally low sac
position
77. Ectopic pregnancy refers to the implantation of a
fertilised ovum outside of the uterine cavity.
Risk factors :
Any tubal abnormality that may prevent passage of the
zygote or result in the delayed transit
Previous tubal pregnancy
h/o tubal reconstructive surgery
IUCD insertion
Increased maternal age
Increased parity
Previous caesarean section
78. TUBAL ECTOPIC : 93 - 97%
Ampullary Ectopic : most common : ~ 70 % of tubal ectopics and ~ 65 - 68 %
of all ectopics.
Isthmal Ectopic : ~ 12 % of tubal ectopics and ~ 11 % of all ectopics
Fimbrial Ectopic : ~ 11 % of tubal ectopics and ~ 10 % of all ectopics
ATYPICAL ECTOPIC PREGNANCIES
Interstitial Ectopic - cornual ectopic : 3 - 4 % :
Ovarian Ectopic - ovarian pregnancy : 0.5 - 1%
Cervical Ectopic - cervical pregnancy : rare < 1 %
Scar Ectopic : site of previous Caesarian section scar : rare
Abdominal Ectopic : rare ( ~ 1.4%)
79. Specific signs include:
1. Demonstration of the pseudosac
2. Peritrophoblastic flow
3. Demonstration of live embryo in the adnexa
Non specific signs include:
1. Correlation with serum beta HCG levels
2. Assessment of the suspected ectopic mass
3. Ectopic tubal ring
4. Free pelvic fluid
80. TVS must be the first line of imaging investigation. BecauseTVS allows for better
visualization of the endometrium, endometrial canal and adnexa thanTAS.
Pseudosac / pseudogestational sac / decidual cast : is an intrauterine fluid
collection surrounded by single decidual layer as opposed to the two
concentric rings of the double decidual sign.
81. Peritrophoblastic
flow : colour flow
doppler imaging
helps in assessing the
peritrophoblastic
flow.
It is high velocity, low
resistance flow with
low RI and PI.
82.
83. Correlation with the serum beta HCG levels:
Negative beta HCG excludes the presence of a live
pregnancy.
Threshold level of beta HCG above which it is
always possible to identify a normal intrauterine
gestational sac
TAS : above 1800mIU/ml
TVS: 500 – 1000mIU/ml
If an intrauterine GS is not identified, ectopic
pregnancy becomes the diagnosis of exclusion.
84. Adnexal mass assessment :
Conditions other than ectopic pregnancy
include:
• Hemorrhagic corpus luteum cyst
• Endometriosis
• Abscess
85. Suspected ectopic mass should be assessed
duringTVS for:
• Local tenderness
• Movement of the ectopic pregnancy separate
from the ovary as the probe pressure is
applied ( specific for tubal pregnancy which is
most common).
86.
87. Free pelvic fluid :
TVS is sensitive in detecting free pelvic fluid.
The presence of the echogenic free fluid or blood
clots in the cul de sac, without sonographic
evidence of an IUP, suggests EP.
88. Patients in whom the site of implantation has
not been identified with certainty have been
categorized as having PUL.
DIAGNOSTICCRITERIA:
Empty endometrial cavity with
1. An inhomogeneous adnexal mass
2. Extrauterine gestational sac with or without a
yolk sac and / or embryonic pole.
Differentials include:
1. Very early IUP
2. Abnormal IUP
3. Ectopic pregnancy
89. Diagnosis is made when a live embryo is
demonstrated in the adnexa in a patient with
an intrauterine gestational sac.
Suspected in patients undergoing ovulatory
induction or IVF.
90.
91. First trimester sonography plays an
important role in establishing the location of
the pregnancy and determining if the
pregnancy is potentially viable.
Knowledge of the landmarks with respect to
the appearance of structures appearing
during first trimester are important in the
triage of patients who present with pain and
bleeding in the first trimester.